Literature DB >> 22777621

T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer.

Ewelina Kluza1, Esther D Rozeboom, Monique Maas, Milou Martens, Doenja M J Lambregts, Jos Slenter, Geerard L Beets, Regina G H Beets-Tan.   

Abstract

OBJECTIVES: To determine the diagnostic value of T2-weighted signal intensity evolution in the tumour for detection of complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer.
METHODS: Thirty-nine patients diagnosed with locally advanced adenocarcinoma and treated with chemoradiotherapy (CRT), followed by surgery, underwent magnetic resonance imaging (MRI) before and after CRT on 1.5-T MRI using T2-weighted fast spin-echo (FSE) imaging. The relative T2-weighted signal intensity (rT2wSI) distribution in the tumour and post-CRT residual tissue was characterised by means of the descriptive statistical parameters, such as the mean, 95th percentile and standard deviation (SD). Receiver operating characteristic curves were used to determine the diagnostic potential of the CRT-induced alterations (Δ) in rT2wSI descriptives. The tumour regression grade (TRG) served as a histopathological reference standard.
RESULTS: CRT induced a significant decrease of approximately 50% in all rT2wSI descriptives in complete responders (TRG1). This drop was significantly larger than for incomplete response groups (TRG2-TRG4). The ΔrT2wSI descriptives produced a high diagnostic performance for identification of complete responders, e.g. Δ95th percentile, ΔSD and Δmean resulted in accuracy of 92%, 90% and 82%, respectively.
CONCLUSIONS: Quantitative assessment of the CRT-induced changes in the tumour T2-weighted signal intensity provides high diagnostic performance for selection of complete responders.

Entities:  

Mesh:

Year:  2012        PMID: 22777621     DOI: 10.1007/s00330-012-2578-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  33 in total

1.  Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer.

Authors:  Seung Ho Kim; Jae Young Lee; Jeong Min Lee; Joon Koo Han; Byung Ihn Choi
Journal:  Eur Radiol       Date:  2010-10-27       Impact factor: 5.315

2.  Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer.

Authors:  M J Gollub; D H Gultekin; O Akin; R K Do; J L Fuqua; M Gonen; D Kuk; M Weiser; L Saltz; D Schrag; K Goodman; P Paty; J Guillem; G M Nash; L Temple; J Shia; L H Schwartz
Journal:  Eur Radiol       Date:  2011-11-20       Impact factor: 5.315

Review 3.  Tumor heterogeneity.

Authors:  G H Heppner
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

4.  Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.

Authors:  Claus Rödel; Peter Martus; Thomas Papadoupolos; Laszlo Füzesi; Martin Klimpfinger; Rainer Fietkau; Torsten Liersch; Werner Hohenberger; Rudolf Raab; Rolf Sauer; Christian Wittekind
Journal:  J Clin Oncol       Date:  2005-10-24       Impact factor: 44.544

5.  Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.

Authors:  Jose G Guillem; David B Chessin; Alfred M Cohen; Jinru Shia; Madhu Mazumdar; Warren Enker; Philip B Paty; Martin R Weiser; David Klimstra; Leonard Saltz; Bruce D Minsky; W Douglas Wong
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

6.  Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer.

Authors:  Quido G de Lussanet; Walter H Backes; Arjan W Griffioen; Anwar R Padhani; Coen I Baeten; Angela van Baardwijk; Philippe Lambin; Geerard L Beets; Jos M A van Engelshoven; Regina G H Beets-Tan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-26       Impact factor: 7.038

Review 7.  Friends or foes - bipolar effects of the tumour stroma in cancer.

Authors:  Margareta M Mueller; Norbert E Fusenig
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

8.  Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy.

Authors:  Leyo Ruo; Satish Tickoo; David S Klimstra; Bruce D Minsky; Leonard Saltz; Madhu Mazumdar; Philip B Paty; W Douglas Wong; Steven M Larson; Alfred M Cohen; Jose G Guillem
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

Review 9.  Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy.

Authors:  Daniel M Patterson; Anwar R Padhani; David J Collins
Journal:  Nat Clin Pract Oncol       Date:  2008-02-26

10.  Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy.

Authors:  Brunella Barbaro; Cecilia Fiorucci; Carmen Tebala; Vincenzo Valentini; Maria Antonietta Gambacorta; Fabio Maria Vecchio; Gianluca Rizzo; Claudio Coco; Antonio Crucitti; Carlo Ratto; Lorenzo Bonomo
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

View more
  15 in total

1.  T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.

Authors:  Sungwon Kim; Kyunghwa Han; Nieun Seo; Hye Jin Kim; Myeong-Jin Kim; Woong Sub Koom; Joong Bae Ahn; Joon Seok Lim
Journal:  Eur Radiol       Date:  2018-06-01       Impact factor: 5.315

Review 2.  Predicting complete response: is there a role for non-operative management of rectal cancer?

Authors:  T Jonathan Yang; Karyn A Goodman
Journal:  J Gastrointest Oncol       Date:  2015-04

Review 3.  Locally Advanced Rectal Cancer: What We Learned in the Last Two Decades and the Future Perspectives.

Authors:  Vivek Srivastava; Aakansha Giri Goswami; Somprakas Basu; Vijay Kumar Shukla
Journal:  J Gastrointest Cancer       Date:  2022-01-03

4.  Pelvic MRI after induction chemotherapy and before long-course chemoradiation therapy for rectal cancer: What are the imaging findings?

Authors:  Marc J Gollub; Ivana Blazic; David D B Bates; Naomi Campbell; Andrea Knezevic; Mithat Gonen; Patricio Lynn; Martin R Weiser; Julio Garcia-Aguilar; Andreas M Hötker; Andrea Cercek; Leonard Saltz
Journal:  Eur Radiol       Date:  2018-10-02       Impact factor: 5.315

5.  Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.

Authors:  Andreas M Hötker; Lisa Tarlinton; Yousef Mazaheri; Kaitlin M Woo; Mithat Gönen; Leonard B Saltz; Karyn A Goodman; Julio Garcia-Aguilar; Marc J Gollub
Journal:  Eur Radiol       Date:  2016-03-05       Impact factor: 5.315

6.  Morphologic predictors of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Authors:  Chongda Zhang; Feng Ye; Yuan Liu; Han Ouyang; Xinming Zhao; Hongmei Zhang
Journal:  Oncotarget       Date:  2017-12-19

7.  Imaging in rectal cancer with emphasis on local staging with MRI.

Authors:  Supreeta Arya; Deepak Das; Reena Engineer; Avanish Saklani
Journal:  Indian J Radiol Imaging       Date:  2015 Apr-Jun

Review 8.  Current approaches and challenges for monitoring treatment response in colon and rectal cancer.

Authors:  Elizabeth McKeown; Daniel W Nelson; Eric K Johnson; Justin A Maykel; Alexander Stojadinovic; Aviram Nissan; Itzhak Avital; Björn Ldm Brücher; Scott R Steele
Journal:  J Cancer       Date:  2014-01-01       Impact factor: 4.207

9.  Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy.

Authors:  Pietro Valerio Foti; Giuseppe Privitera; Sebastiano Piana; Stefano Palmucci; Corrado Spatola; Roberta Bevilacqua; Luigi Raffaele; Vincenzo Salamone; Rosario Caltabiano; Gaetano Magro; Giovanni Li Destri; Pietro Milone; Giovanni Carlo Ettorre
Journal:  Eur J Radiol Open       Date:  2016-07-18

10.  Re-Staging Following Long-Course Chemoradiotherapy For Rectal Cancer: Does It Influence Management?

Authors:  A McBrearty; K McCallion; R J Moorehead; I McAllister; K Mulholland; R Gilliland; W J Campbell
Journal:  Ulster Med J       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.